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Abstract
Background: Antibody fragments selected from large combinatorial libraries have numerous
applications in diagnosis and therapy. Most existing antibody repertoires are derived from human
immunoglobulin genes. Genes from other species can, however, also be used. Because of the way
in which gene conversion introduces diversity, the naïve antibody repertoire of the chicken can
easily be accessed using only two sets of primers.
Results: With in vitro diagnostic applications in mind, we have constructed a large library of
recombinant filamentous bacteriophages displaying single chain antibody fragments derived from
combinatorial pairings of chicken variable heavy and light chains. Synthetically randomised
complementarity determining regio n s  a r e  i n c l u d e d  i n  s o m e  o f  the heavy chains. Single chain
antibody fragments that recognise haptens, proteins and virus particles were selected from this
repertoire. Affinities of three different antibody fragments were determined using surface plasmon
resonance. Two were in the low nanomolar and one in the subnanomolar range. To illustrate the
practical value of antibodies from the library, phage displayed single chain fragments were
incorporated into ELISAs aimed at detecting African horsesickness and bluetongue virus particles.
Virus antibodies were detected in a competitive ELISA.
Conclusion: The chicken-derived phage library described here is expected to be a versatile source
of recombinant antibody fragments directed against a wide variety of antigens. It has the potential
to provide monoclonal reagents with applications in research and diagnostics. For in vitro
applications, naïve phage libraries based on avian donors may prove to be useful adjuncts to the
selectable antibody repertoires that already exist.
Background
Recombinant antibodies derived from phage display
libraries [1-10] are by now well established in medicine
and biotechnology. A major objective of recombinant
antibody research so far has been to develop new thera-
peutic agents for use in human patients. Accordingly,
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most of the existing large combinatorial libraries are
based upon human immunoglobulin genes. Phage anti-
bodies can, however, be derived from a number of alter-
native donors such as rabbits [11], camels [12], cattle [13],
sheep [14] and chickens [15]. From a practical point of
view, the chicken is a particularly attractive source of
immunoglobulin genes. To amplify each of the V gene
segments in the human or mouse requires a number of
PCR primer sets. In contrast, the chicken antibody reper-
toire can be accessed relatively easily because of the way in
which its diversity is generated. In birds, single immu-
noglobulin variable and joining gene segments at each
heavy (H) and light (L) chain locus are subjected to VJ
rearrangement in the case of the L chain and VDJ for the
H chain. Variability then arises by gene conversion result-
ing from the incorporation of pseudo V region genes [16-
19]. As a result, essentially all chicken V regions can be
expected to have virtually identical amino acid sequences
at both termini. The naïve antibody repertoire can thus be
conveniently amplified by using only a single set of PCR
primers for the H chain and another for the L chain. This
property was first exploited by Davies and co-workers [15]
who constructed and expressed an scFv library derived
from chicken bursal lymphocyte RNA. They demonstrated
the potential of the chicken as a source of recombinant
antibody fragments by constructing a relatively small (2.7
× 107  clones), but nonetheless effective, naïve library
which yielded scFv phage antibodies against three differ-
ent proteins. Antibody fragments that recognise proteins
are not always readily obtained from small libraries of
human origin [3].
The accessibility by PCR of chicken antibody gene reper-
toires also facilitates the construction of immune phage
libraries [20-22]. If, however, the aim is to bypass immu-
nisation entirely, it becomes important to increase the
probability of isolating high affinity binders by having as
large and diverse a repertoire as possible [5-7,23,24].
While the construction of a large antibody library is not a
trivial undertaking, the technology ultimately offers sev-
eral advantages when compared to conventional sources
of antibodies, particularly the way in which the need for
animals or cell culture facilities is circumvented. To be
able to understand and control new or re-emerging dis-
eases, new reagents are constantly required for use in vet-
erinary and agricultural diagnostic tests and as research
tools. A rapid and economical way of obtaining pathogen-
specific antibodies is therefore likely to be especially use-
ful in developing countries where budgets and facilities
are often severely limited. Because of the potential of
recombinant antibody technology to provide reagents
that can be used in a variety of standard immunodiagnos-
tic tests [4,25-29] we have constructed a large (approxi-
mately 2 × 109 clones) and diverse scFv library, primarily
with in vitro diagnostics in mind. This library combines
the naïve chicken immunoglobulin repertoire with a sub-
library in which amino acid residues comprising the third
H chain complementarity determining region (CDR3)
have been synthetically randomised. The overall reper-
toire was found to be diverse enough to yield antibody
fragments that recognise haptens, proteins and viruses. Its
potential as a source of in vitro veterinary diagnostic rea-
gents was illustrated by finding antibodies which could be
used in ELISA to detect African horsesickness virus
(AHSV), bluetongue virus (BTV) and BTV antibodies.
Results
Antibody fragment library construction
With the goal of creating a widely diverse antibody reper-
toire, two separate phage display sublibraries were con-
structed. The first was aimed at representing the naïve
immunoglobulin repertoire of the chicken. For this,
pooled RNA extracted from five chicken bursae was used.
A strategy was employed in which the 5' PCR primer used
to amplify the L chain and the 3' of the H chain included
complementary sequences, which when extended, would
serve to link the H and L chains via a (Gly4 Ser)3 linker
[30]. This naïve sublibrary comprised a total of 3.75 × 108
phage clones. DNA from a number of these clones was
sequenced to verify that joining had taken place correctly
and that reading frames had been preserved. This analysis
also revealed that the CDR3 of the H chain of the
sequenced clones varied in size from 6 to 19 residues (Fig-
ure 1A). Attempts to use this same joining strategy to
introduce artificially randomised CDR3s of defined size
were not consistently successful. Accordingly, a separate
linker sequence was amplified from a DNA template
obtained from a clone in the naïve library and splicing by
overlap extension (SOE) PCR [31] was used to join sepa-
rate H, L and linker sequences [32]. The H chains included
artificially randomised CDR3s ranging in size from 6 to 14
amino acid residues. A separate set of amplification and
joining reactions was carried out for each size of CDR.
After joining, the H and L chain sets were ligated into the
display vector pHEN I and each set was separately electro-
porated into competent bacterial cells. DNA sequencing
showed that randomised CDR3 sequences of defined
lengths had been successfully incorporated into the heavy
chains (Figure 1B). Based on the number of primary trans-
formants, phages were mixed proportionally to prevent
over-representation of any of the synthetic CDR3s in the
synthetic sublibrary. The naïve and randomised sublibrar-
ies were similarly combined to yield the final repertoire
consisting of approximately 2 × 109 primary transform-
ants. This required a total of 190 separate electropora-
tions. Sequencing the DNA of 70 random clones revealed
that approximately 65% had the potential to express in-
frame scFvs. The completed library thus contained combi-
natorial pairings of naïve H and L chains as well as sets ofBMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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synthetically randomised H chains paired with natural
chicken L chains.
Selection of specific antibodies
To test its viability as a source of antibody fragments, the
entire library was subjected to four rounds of selection
using several model haptens, proteins and viruses. Res-
cued phage particles obtained after each round of panning
were then tested in a polyclonal phage ELISA to determine
whether enrichment for binders had taken place with each
successive selection step. An increase in specific ELISA sig-
nals was evident with the phage pools obtained after
Amino acid sequences of VH CDR3s Figure 1
Amino acid sequences of VH CDR3s. Amino acid sequences of scFv clones showing the VH CDR3s and their flanking 
regions in the naïve (A) and the semi-synthetic (B) repertoires which were combined to make up the final Nkuku recombinant 
antibody library. The clones from the naïve library were randomly picked while representatives from each predetermined size 
class are shown in the case of the synthetic repertoire. Identical amino acid residues are shown by dashes (-) while dots (.) indi-
cate spaces introduced to align sequences.
A
..RLQLNNLRAEDTGTYYCAKAAGXXXXXXXXXXXTAGSIDAWGHGTEVIVSS..
..___________________SAGLTWYTCG........______________..
..___________________DASSDGWNAGW.......______________..
.._____________I_F___SAAGSCINKCAGGVGS..______________..
..___________________HSGSNCDGAGC.......______________..
.._____S_______I___G_DATTS.............______________..
..____________A____V_ESTSGGWNAGR.......______________..
..____________A______NAYGSGICYADD......______________..
.._____________I_____TTGSGCNYGSCYASQ...______________..
.._____S____________RGPGGVDS...........______________..
..____S__________F___YGYGYCGSGGWCAAGS..______________..
..___________________TAGCLYTDCSVGS....._____R________..
. .________VD__A______AASYECPYGYTCWGYTAS______________. .
..____________AI_F___AAGSAGD...........______________..
..___________________SASSCGGNCWYADSAGS.______________..
..____________A______SVSTNYNGDQ........______________..
B
..RLQLNNLRAEDTGTYYCAKAAGXXXXXXTAGSIDAWGHGTEVIVS..
. .___________________NDYKH........________E____..
. .___________________NGLMG........________G____..
. .___________________QCKPL........________E____..
. .___________________SGYKQ........________E____..
. .__________________QMWGGP........______R_RN___..
. .K_E_I_IT_E_________LRAGFEVVI...._____________..
. .___________________HTTHPPFGL...._____________..
. .___________________KTSSSDIEA...._____________..
. .___________________AKTLKPVCK...._____________..
. .___________________TMNTESSHK...._____________..
. .___________________PNATWKKKKPRAY_____________..
. .___________________SRKPRTLTTQQAQ_____________..
. .___________________ATAAREKHHGFSL______P_Q____..
. .___L_N___E_________RAPKSPQTRPLME_____________..
. .__QP_S___E_________HWSLSVYLSMRRR___G_________..
Synthetic CDR3
Naïve CDR3BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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Polyclonal phage ELISA Figure 2
Polyclonal phage ELISA. Polyclonal phage ELISAs showing the increase in specific signal with successive rounds of panning. 
Phages were selected by panning on immobilised proteins, haptens and viruses. Pools released from the affinity matrix after 
each round of selection were amplified, purified by precipitation and tested for binding to the homologous target and several 
heterologous antigens: BSA = bovine serum albumin, MP = 2% milk powder in PBS, MBP = maltose binding protein, F-BSA = 
fluorescein-conjugated bovine serum albumin, N-BSA = 4-hydroxy-3-iodo-5-nitrophenylacetic acid conjugated to bovine serum 
albumin, AHSV = purified African horsesickness virus particles, BTV = purified bluetongue virus particles, CMV = purified 
cucumber mosaic virus particles, CYT = cytochrome C, THY = porcine thyroglobulin, CHY = chymotrypsinogen, KLH = key-
hole limpet haemocyanin, TEL = turkey egg lysozyme. The homologous antigens in each case were: A) F-BSA, B) N-BSA, C) 
KLH, D) TEL, E) CYT, F) THY, G) CMV, H) AHSV and I) BTV. Figures on the X axis indicate the panning round of which the 
output was tested for polyclonal binding. The figure 0 refers to the unpanned library.
  A.     B.       C.
   D.      E.      F.
   G.      H.        I.
0 1 2 3 4
CHY
N-BSA
TEL
MP
THY
0
0.5
1
1.5
2
2.5
3
3.5
A
 
4
9
2
 
n
m
0  1  2  3  4
CHY
N-BSA
MP
TEL
THY
0
0.5
1
1.5
2
2.5
3
3.5
A
 
4
9
2
 
n
m
0  1  2  3  4
CHY
CYT
MBP
MP
THY
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
A
 
4
9
2
 
n
m
0 1 2 3 4
BTV
KLH
AHSV
F-BSA
BSA
MP
0
0.5
1
1.5
2
2.5
A
 
4
9
2
 
n
m
0 1 2 3 4
BTV
KLH
AHSV
F-BSA
BSA
MP
0
0.1
0.2
0.3
0.4
0.5
0.6
A
 
4
9
2
 
n
m
0  1  2  3  4
MP
KLH
CMV
0
0.5
1
1.5
2
2.5
A
 
4
9
2
 
n
m
0 1 2 3 4
BTV
KLH
AHSV
F-BSA
BSA
MP
0
0.5
1
1.5
2
2.5
3
A
 
4
9
2
 
n
m
0 1 2 3 4
BTV
KLH
AHSV
F-BSA
BSA
MP
0
0.5
1
1.5
2
2.5
A
 
4
9
2
 
n
m
0 1 2 3 4
CHY
TEL
MP
THY
BSA
N-BSA
0
0.5
1
1.5
2
2.5
3
A
 
4
9
2
 
n
mBMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
Page 5 of 14
(page number not for citation purposes)
panning on the conjugated haptens fluorescein (F-BSA;
Figure 2A) and BSA-coupled 4-hydroxy-3-iodo-5-nitroph-
enylacetic acid (N-BSA; Figure 2B). Figure 2C,2D,2E,2F
also shows binding to the proteins keyhole limpet haemo-
cyanin (KLH), turkey egg lysozyme (TEL), cytochrome C
(CYT) and porcine thyroglobulin (THY). Antibody pools
reactive in ELISA with purified cucumber mosaic virus
(CMV), AHSV and BTV (Figure 2G,2H,2I) were also
obtained. No enrichment was obtained during selections
performed on maltose binding protein (not shown).
Antigen-specific phage pools selected on some of the
viruses and proteins were chosen for further characterisa-
tion. Individual phage clones were picked and tested in
ELISA for their ability to recognise antigen. Using an
ELISA absorbance of greater than 0.2 as the criterion for
binding, 99% of the bacterial clones tested secreted fusion
phages that specifically recognised CMV. With BTV, 76%
were positive and with AHSV the figure was 61%. Using
the protein KLH as the target, 44% of the clones were spe-
cific binders. In the absence of exhaustive sequence data,
however, these figures do not necessarily imply that each
binder represented a unique clone. While phage titres
were not normalised for each ELISA determination, as a
rule, no reactivity with unrelated antigens was discernible
indicating that improved binding to the target with each
round of panning was due to specific enrichment and not
an increase in "stickiness" and/or phage titre. One excep-
tion was that the polyclonal phage displayed antibodies
selected on TEL showed an unexpected cross-reactivity
with porcine thyroglobulin (Figure 2D). Selecting single
clones, however, made it possible to isolate a phage dis-
played antibody that recognised only TEL and another
that recognised both TEL and thyroglobulin (not shown).
In an attempt to establish whether any of the binding anti-
bodies were derived from the component of the library
that included the synthetically randomised VH CDR3s,
DNA coding for several virus-specific binders was
sequenced, namely three each that recognised BTV and
AHSV and five that bound to CMV. Based on the nucle-
otide sequences used to introduce the synthetic CDR as
well as the presence of only NNK codons in the CDR3
itself, one clone from each of these groups could be
shown to have originated from the synthetic component
of the final library (Figure 3). No two L or H chains were
identical and (surprisingly) one clone (C31) that bound
to CMV lacked its entire VH region which indicates that its
total binding activity resides in the VL region. A number
of phage antibody clones specific for BTV and CMV were
tested for their ability to bind as soluble scFvs. Soluble
fragment production was induced using IPTG. Of four-
teen BTV binders, only two showed ELISA reactivity in
both forms. With CMV, the figure was 85 out of 96, but
since their DNA sequences were not determined, this fig-
ure may reflect multiple copies of fewer actual binders.
For BIACORE affinity determinations, the scFvs were
directly tested for their ability to bind in soluble form.
After affinity purification, yields of soluble fragments
ranged from 4 ng to 2,5 µg per millilitre of culture
supernatant.
Amino acid sequences of CDRs of binding antibodies Figure 3
Amino acid sequences of CDRs of binding antibodies. Amino acid sequences of VH and VL CDRs of antibodies selected 
from the Nkuku library. Asterisks (*) denote clones which have high probability of having been derived from the portion of the 
library into which synthetic CDR3s were introduced. The entire H chain of clone C31 was absent, but the fragment bound to 
CMV particles in ELISA (not shown). The antigens recognised by each of the individual clones are indicated in the figure. Dots 
(.) indicate spaces introduced to align sequences, x denotes ambiguous bases. (Genbank accession numbers: Lca12, AY366194; 
Hca12, AY366195; C6, 366196; E8-10, AY366197; E8-3, AY366198; H2, AY366199; C23, AY366200; C24, AY366201; C26, 
AY366202; C29, AY366203; C31, AY366204)
AHSV
Lca12 SYPMG DI.DGDGSGTYYGAAVK TT.GNSWTAGKI SGSDSSYG..YYG WDDERPS GNADSSYDG
Hca12* TYDMA GI.ENDGSGTWYAPAMK ....EDNYFxNI SGSSGSYG..WY. DSNKRPS GDWNSA..G
C6 SYGMQ GISNSDGSWAGYGAAVK TADGYFGWGxSI SGSGSSYG..WF. DSSSRPS GSRDSSS.G
BTV
E8-10* DRAMH VISNSGGTE...YGAAVK DVYGTNWGGYADT..I SGGG.....SWYG DNTNRPS GSYDSSAGNVG
E8-3 DRGMG SISNSGSNTA..YGAAVK GAYGGWYADD.....I SGGDD....SWYG DNTNRPS GSWNSTTHSG.
H2 SYDMF GIGSTGSGSKTNYGAAVD SPYDGSGGYWNYGSSI SGSS.....SGYG QNDKRPS GTIDSSPSYVA
F3 DRGMA SISNSGSSAY..YAPAVK SGYGGGAWG..DT..I SGDDS.....WYG INNQRPS GSYDSSADS.V
F10 SYQMF AITNDGGGTN..YGSAVK DVYGNSYGFGVDS..I SGGGSYAGSYYYG DNTNRPS GGYDSSTKAGI
CMV
C23 SDRGMQ GIDDDGSFTAYGAAVK GAYANYYVDE....I SGGDYYG...... ENNNRPS GSGDSNGDG.
C24 SSYSMG EITEDGGDTDYGAAVK DAHSDSIYYLDGGSI SGGSYSYG..... WDDERPS GSADSSGA..
C26 SSMAWV SISKDGGGTEYGAAVK SIDSDDWIADD...I SGGSSDDGSYYYS YNDKRPS GSWDSSYVG.
C29* SSYGMG GIDDDGSYTDYAPAVK NAGGSGWIADN...I SGGDSYAGSYYYG ENDKRPS GSGDSSTDAG
C31 SGGDSYYGSYYYS DNTNRPS GAYDSSYVG.
L CDR2 L CDR3 H CDR1 H CDR2 H CDR3 L CDR1BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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Sandwich ELISA to detect orbiviruses
African horsesickness is an economically important dis-
ease in southern Africa and elsewhere. It is caused by
AHSV, an orbivirus (family Reoviridae) containing a char-
acteristic double-stranded RNA segmented genome
within a double-shelled capsid. AHSV can be detected by
using a sandwich ELISA in which the virus particle is first
captured on an affinity matrix of immobilised antibodies
and then detected by a second layer of virus-specific anti-
bodies followed by labelled anti-immunoglobulin rea-
gents [33,34]. Phage antibodies are particularly suitable in
this format since the detecting signal is amplified by the
multiple copies of pVIII, the major capsid protein of the
fusion phage. To determine whether the chicken antibody
library could provide phage antibodies that could act as
the second antibody in the sandwich, round three output
phages (Figure 2H) were screened by panning on 2.5 µg/
ml of AHSV instead of the usual concentration of 20 µg/
ml. This was done in an attempt to exclude low or
medium affinity binders by using a limiting amount of
target antigen. Only three virus-specific scFvs were found
after this high-stringency round of selection. The clone
that gave the highest signal (Figure 3; clone Lca12) was
chosen for use as a detecting antibody in the sandwich
ELISA. For this assay, virus particles were trapped from
suspension using virus-specific rabbit IgG and detected
using the phage displayed scFv, an anti-pVIII mouse mon-
oclonal antibody (mAb) and a labelled anti-mouse IgG.
At a concentration of 40 ng/ml virus, equivalent to 2 ng/
well, the assay produced an absorbance at 492 nm of
greater than 0.5 (Figure 4A). A phage antibody (Figure 3;
clone H2) selected from the fourth round pool of BTV
binders was used in a similar assay to detect BTV particles
(Figure 4B).
Inhibition ELISA
The specificity of an antigen-antibody interaction can be
shown by inhibiting the binding with a different antibody
directed against the same antigen. Such inhibition assays
are used to detect antibodies against BTV for the purposes
Sandwich ELISA for virus detection Figure 4
Sandwich ELISA for virus detection. Double antibody sandwich ELISA absorbance values obtained in which dilutions of 
(A) AHSV or (B) BTV particles were trapped from suspension using virus-specific rabbit IgG and detected using phage-dis-
played scFvs (clone Lca12 for AHSV, clone H2 for BTV; see Figure 3) as the second antibody in the sandwich. Binding phages 
were detected with a pVIII-specific mAb and a peroxidase-labelled anti-mouse IgG immunoglobulin. Each point represents the 
average of three determinations. Error bars show one standard deviation from the mean.
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of regulating livestock exports. To determine whether
BTV-specific scFvs could replace the traditional mAbs usu-
ally used in these tests, BTV particles were immobilised by
adsorption to a microtitre plate well and immune- and
control sera from rabbits or sheep were added before
introducing a BTV-specific scFv (Figure 3; clone H2). The
binding of the antibody fragment was inhibited by virus-
specific antibodies in the sera, the degree of inhibition
being dependent on the serum dilution. Rabbit antiserum
directed against both the homologous serotype 10 as well
as the heterologous serotype 4 showed inhibition. Simi-
larly, sheep antisera raised against three heterologous
serotypes (2, 4 and 9) could inhibit the interaction. Non-
immune sera from either species had no effect on the
ELISA signal and filamentous phage displaying no scFvs
did not bind to the immobilised antigen (Figure 5).
Affinity of selected scFvs
To determine whether binding affinities of Nkuku-derived
scFvs had the potential to be in the same range as those
obtained from other large libraries, scFvs directed against
three antigens of widely different molecular weights were
chosen for BIACORE analysis. These were fluorescein
(586 Da), cytochrome C (12.4 kDa) and KLH (400 kDa).
All determinations were done in duplicate using separate
preparations of scFvs. The experimental results were fitted
to the BIAevaluation 1:1 Langmuir binding model. Visual
comparison and the calculated χ2 values indicated an
Inhibition ELISA Figure 5
Inhibition ELISA. Inhibition of binding of the phage displayed scFv H2 in a competitive ELISA. Purified BTV serotype 10 par-
ticles were immobilised directly on a plastic surface. The samples to be tested for inhibition were then added, followed by the 
phage displayed scFv H2, an anti-pVIII monoclonal antibody and an enzyme-labelled anti-mouse IgG immunoglobulin. The 
shaded bars depict the average absorbance value of two determinations while the upper and lower values are shown by the 
error bars. Test samples used in the inhibition step were: (a) 2% solution of fat-free milk; (b-d) three different non-immune 
rabbit sera; (e) 1/9 and (f) 1/81 dilutions of anti-BTV serotype 4 rabbit immune serum; (g) 1/9 and (h) 1/81 dilutions of anti-BTV 
serotype 10 rabbit antiserum; (i) 1/9 and (j) 1/81 dilutions of non-immune sheep serum; (k) 1/9 and (l) 1/81 dilutions of sheep 
antiserum directed against BTV serotype 2; (m) 1/9 and (n) 1/81 dilutions of sheep antiserum against BTV serotype 4; (o) 1/9 
and (p) 1/81 dilutions of BTV serotype 9-specific sheep antisera. The background binding of non-fusion phage to the immobi-
lised BTV serotype 10 is shown by (q).
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acceptable fit to the model. The high affinities of these
three binders (nanomolar or less; Table 2) show that they
compare well with antibody fragments derived from naïve
libraries of human origin [5,7].
Discussion
Most recombinant antibody libraries are based on human
immunoglobulin genes. While this is obviously desirable
in human therapy, for veterinary diagnostic tests or other
in vitro applications, specific binding reagents could be
obtained from any animal source. With veterinary and
agricultural applications in mind, we were able to con-
struct a diverse phagemid-based chicken scFv library con-
sisting of approximately two billion clones. Several other
large antibody libraries have been given a variety of names
(e.g. "Nissim", "Vaughan", "HuCal", "n-CoDer" etc).
Accordingly, we suggest for our library the name "Nkuku",
derived from the Zulu word "nkukhu", which means
"chicken".
To maximise the range of potential paratopes [3], the
Nkuku library makes use of the natural L and H chains of
the chicken immunoglobulin repertoire together with a
selection of synthetically randomised H chain CDR3s of
defined sizes. The success of this diversification strategy
was shown empirically by obtaining scFvs that recognised
a number of haptens, proteins and viruses. Isolating a
variety of target-specific phage antibodies further demon-
strates the suitability of the chicken as a donor of immu-
noglobulin genes for use in constructing non-immune
antibody libraries [15]. Two different approaches to the
combinatorial joining of H and L chains were used. The
use of amplification primers that included the linker
sequences [21] was not feasible for incorporating ran-
domised H chain CDR3s owing to the impractically long
oligonucleotides required (not shown). For constructing
the synthetically randomised sublibrary, the classical
strategy of employing a separate linker sequence [32] was
therefore used. For similar reasons, it was also not possi-
ble to reliably include synthetic CDR3s of longer than 14
residues. The final antibody pool therefore relies on the
chicken's natural H chain repertoire to provide these
longer CDRs. Producing the antibody library was never-
theless straightforward, since all amplification steps were
facilitated by the relatively few PCR primers required.
The amino acids comprising the CDR3 of the human
immunoglobulin H chain show the most variability and
usually make the dominant contribution to binding [35-
37]. In the widely distributed human antibody library
made by Nissim and co-workers [4], it is this region that
has been artificially randomised. Sequencing the DNA of
several unselected clones from our chicken library
revealed VH CDR3 regions ranging in size from 6 to 19
Table 1: Nucleotide sequences of DNA primers used for amplifying and sequencing chicken immunoglobulin genes
Primer Sequence
GSfor 5' GGGGCCACGGGACCGAAGTC 3'
GSrev2 5' CGCTGACACCGAGGAC 3'
LCNOT1 5' TGATGGTGGCGGCCGCATTGGGCTG 3'
Sfi1L 5' GTCCTCGCAACTGCGGCCCAGCCGGCCCTGATGGCGGCCGTGACG 3'
RandVH * 5' GACTTCGGTCCCGTGGCCCCATGCGTCGAT[MNN]n TTTGGCGCAGTAGTAGGTGCCGGTGTCCTC 3'
OP52 5' CCCTCATAGTTAGCGTAACG 3'
M13rev 5' CAGGAAACAGCTATGAC 3'
NEWLVarL 5' TCAGGTGGAGGTGGCTCTGGCGGAGGCGGATCGGCGCTGACTCAGCCGTCCTCGG 3'
NEWLVarH 5' CCGCCAGAGCCACCTCCACCTGAACCGCCTCCACCGGAGGAGACGATGACTTCGG 3'
* M = A/C, N = A/C/G/T, n = 5–13
Table 2: Kinetic and binding parameters for three scFvs selected from the Nkuku library1.
scFv ka (1/Ms) kd (1/s) KD (M)
anti-F-BSA 7 × 106 1.68 × 10-2 2.4 × 10-9
anti-CYT 4.29 × 106 3.64 × 10-3 3.5 × 10-10
anti-KLH 2.41 × 106 3.64 × 10-3 2.83 × 10-9
1Association and dissociation rate constants were measured using BIACORE. Each value represents the average of two independent determinations 
on the same chip surface.BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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residues. The CDR3 regions of the L chain were from 5 to
13 amino acids long, also showing wide variability. Since
chicken IgY has essentially the same arrangement of CDRs
as mammalian IgG, we emulated the Nissim library
approach by incorporating our synthetically randomised
sequences into the VH CDR3 region [4]. To verify that the
randomised VH CDR3 sequences were used in our func-
tional antibodies, the DNA coding for 11 antibody clones
that had been selected by panning on three different
immobilised viruses was sequenced. It was expected that
in the clones originating from the artificially introduced
CDR3 sequences, all residues flanking the CDR would be
identical to those of the primers used to introduce them.
In addition, since NNK codons were used for randomisa-
tion, every third base in the synthetic CDR should be
either G or T. On the basis of these criteria, three out of the
11 clones appeared to originate from the synthetically
introduced repertoire. All L chains were found to be differ-
ent. In the case of both BTV and AHSV, one out of three
binding clones probably originated from the synthetic
repertoire while with CMV the proportion was one in five.
We also found that one of the antibodies that bound to
CMV was lacking its entire H chain (Figure 3; clone C31).
Its binding in ELISA was nonetheless essentially indistin-
guishable from that of several other intact phage dis-
played scvFs (not shown). It is unlikely that the absent H
chain represents a sequencing artefact since the entire
insert was sequenced in both directions using primers that
anneal to the vector. Extensive gene conversion in chicken
L chains has been observed before [21] and raises the
intriguing possibility that it may be possible to develop a
functional single domain antibody library from only the
chicken L chain.
Not all chicken library antibodies that bound as phage
displayed fragments could be shown to bind in ELISA
when expressed as scFvs. This is not unexpected and could
be due either to low expression levels or to a low intrinsic
affinity when the fragment is used outside the phage dis-
play context. The phage particle with its displayed anti-
body fragment can nevertheless be a useful ELISA reagent
when used as the second antibody in a sandwich format.
This was shown in the immunoassy (Figure 4A) designed
to detect AHSV particles immobilised on a rabbit IgG
affinity matrix using clone Lca12 (Figure 3). An analogous
assay for the structurally similar BTV, but using fusion
phages from a human antibody library [4], has been
described previously [25]. The ability of Nkuku library-
derived fusion phages to be incorporated into an assay for
viral antibodies as opposed to antigens was shown by the
BTV-specific fusion phage designated H2 which could be
inhibited by immune rabbit and sheep sera (Figure 5).
Inhibition was not confined to antibodies directed against
the homologous serotype, indicating that H2 probably
recognises an antigenic determinant that occurs on more
than one viral serotype. Alternatively, it may bind to a
unique region that is located in close proximity to one or
more cross-reactive epitopes, such that it is functionally
inhibited by heterologous antibodies. Our results show
that the Nkuku library can be used to obtain potentially
useful and specific assay reagents without resorting to
hybridomas. In the case of viruses possessing a multiplic-
ity of serotypes such as the orbiviruses AHSV and BTV
[38], recombinant technology may be the only practical
way of obtaining antibodies that can identify each indi-
vidual serotype.
A DNA clone that codes for a particular recombinant anti-
body is a virtually inexhaustible source which can be une-
quivocally identified by its nucleotide sequence. Critical
immunoassay reagents can therefore be fully character-
ised. In addition, it is often possible to engineer or evolve
phage antibodies showing improved stability or affinity
[39]. Most of the antibodies described here bound
strongly in ELISA without further modification and at
least one (F10) could survive at least one freeze-thaw
cycle. This may not always be the case and if the aim is to
develop immunoassays for use under field conditions e.g.
in Africa, it may be necessary to select for temperature-sta-
ble variants. The use of chicken frameworks may be
advantageous for this purpose since they have evolved to
function at a body temperature approximately 5°C higher
than that of humans.
Conclusions
On the basis of the evaluation described here, this
chicken-derived "Nkuku" phage library is a potentially
versatile source of recombinant antibody fragments which
should find many applications in areas such as immuno-
diagnostics [40] and proteomics [41]. Unless steps are
taken to humanise them [21], such avian antibodies are
unlikely to be useful for human therapeutics. Human V
genes may, however, sometimes lack the intrinsic features
required to produce antibodies that can recognise all
epitopes with high affinity [42]. For in vitro use, large non-
immune phage libraries based on avian donors such as
the one described here may therefore prove to be a useful
additional source of binding reagents.
Methods
Antigens and immunochemical reagents
Attenuated AHSV serotype 3 and BTV serotype 10 (both
members of the genus Orbivirus, family Reoviridae) were
obtained originally from the vaccine factory (now Onder-
stepoort Biological Products Limited) at the then Veteri-
nary Research Institute. The viruses were multiplied in
BHK (BTV) or CER (AHSV) cells and purified by sucrose
density-gradient centrifugation [43]. Rabbit and sheep
sera were supplied by the Biochemistry and Virology Divi-
sions of the Onderstepoort Veterinary Institute. The sheepBMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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sera are used routinely as reference standards by the OIE
World Reference Centre for bluetongue virus. Purified
cucumber mosaic virus particles were a generous gift from
Dr G. Pietersen, Plant Protection Research Institute, Rood-
eplaat. KLH, F-BSA, porcine thyroglobulin, TEL and cyto-
chrome C were from Sigma. N-BSA was prepared from the
succinimide ester of 4-hydroxy-3-iodo-5-nitrophenylace-
tic acid -CAP-OH (NIP-CAP-OSU; Genosys) and BSA frac-
tion V according to the method described by the Medical
Research Council (Cambridge, UK) in the instructions
issued with their "Nissim" antibody library. B62-FE2, a
mAb specific for an epitope on the phage coat protein VIII
of filamentous male-specific phages, was from Progen
Biotechnik (Heidelberg) while a horseradish peroxidase
(HRP)-labelled anti-M13 mAb was purchased from Amer-
sham Pharmacia Biotech (UK). HRP labelled rabbit-anti-
mouse immunoglobulins were supplied by Dako (Den-
mark). A murine hybridoma (Mycl-9E10; ECACC
85102202) producing a mAb (9E10) specific for the c-myc
epitope tag, was obtained from the European Collection
of Cell Cultures (CAMR, UK). The hybridoma was cul-
tured in protein-free hybridoma medium (Invitrogen
Corporation).
Construction of the recombinant antibody library
Five different 5-week old white leghorn hens were killed
by overdosing with pentobarbitone and their bursae
removed (approved by the Animal Ethics Committee,
Onderstepoort Veterinary Institute). Total RNA was
extracted with TRI-Reagent (Molecular Research Center,
Cincinnati, OH, USA). Oligo d(T)16 primer, RNase inhib-
itor, MuLV reverse transcriptase (all from the Perkin Elmer
Gene Amp RNA PCR core kit, Roche), 10x Ex Taq buffer
and dNTPs (both from TaKaRa, Japan) were used for
cDNA synthesis. The reaction products were used directly
as cDNA templates to construct two different scFv gene
sublibraries; the first was a naïve library while the second
included a synthetically randomised H-chain CDR3
region. In both sublibraries the VH and VL genes were
joined by a (Gly4-Ser)3 linker [30], but two different strat-
egies were followed. For the naïve sublibrary two sets of
primers were used in the primary amplification. The VH
and VL sequences were first amplified using primer sets
Sfi1L/NEWLVarH and NEWLVarL/LCNOT1 (Table 1).
Amplification reactions consisted of 8 µl 10x TaKaRa
buffer, 2.5 pmol of each primer, 2.5 units (U) of TaKaRa
Ex Taq enzyme, the 20 µl reverse transcription product
(above) and water to a final volume of 100 µl. PCR was
for 30 cycles at 94°C for 1 minute (min), 60°C for 1 min,
72°C for 1 min followed by a final extension period of 1
min at 72°C. The primers NEWLVarH and NEWLVarL
contained overlapping linker sequences to allow the two
genes to be spliced by overlap extension [21,31]. Prior to
splicing, the amplified genes were purified using a
QIAquick PCR purification kit (QIAGEN, Germany).
Further purification entailed electrophoresis on a 2% aga-
rose gel (Seakem ME) prepared in 1 × TAE supplemented
with a final concentration of 10 µg/ml crystal violet [44]
followed by extraction from the gel using a QIAquick gel
extraction kit (QIAGEN). Splicing was in 100 µl reaction
volumes comprising 10 µl 10x TaKaRa buffer, 8 µl TaKaRa
dNTPs, 100 ng VL chain DNA, 100 ng VH chain DNA, 2.5
U TaKaRa Ex Taq DNA polymerase, 3 U Promega Pfu DNA
polymerase [45] and water to a final volume of 100 µl.
The reaction components were transferred from ice to a
preheated (94°C) thermal cycler. This was followed by 15
cycles at 94°C for 1 min, 60°C for 1 min, 72°C for 2 min
and a final extension at 72°C for 5 min. Pullthrough
amplification reactions consisted of 10 µl 10x TaKaRa
PCR buffer, 8 µl TaKaRa dNTPs, 20 pmol Sfi1 primer, 20
pmol LCNOT1 primer, 2 µl spliced product, 2.5 U Ex Taq
DNA polymerase and water to a final volume of 100 µl.
Reaction mixtures were transferred from ice to a thermal
cycler block at 94°C. A preheating step of 1 min at 94°C
was followed by 25 cycles of 94°C for 1 min, 60°C for 1
min, 72°C for 2 min and a final extension at 72°C for 5
min. The product was gel purified as above. The joined VH
and VL genes were digested overnight at 50°C with 20 U
Sfi1 (Roche) per µg DNA in 100 µl buffer M (Roche)
supplemented with 0.1 mg/ml acetylated BSA. For over-
night cutting with Not1 at 37°C, digestion conditions
were adjusted by the addition of 1.5 µl of 5 M NaCl, 6 µl
1 M Tris (pH 8.0), 0.5 µl 10 mg/ml acetylated BSA, 20 U
Not1 (Roche) per µg DNA and water to final volume of
150 µl. The digested DNA was gel purified as above.
The phagemid vector pHEN I (obtained from the Medical
Research Council, UK) was purified from an overnight
TG1 bacterial culture using a QIAGEN Plasmid Midi Kit.
Restriction enzyme digestion conditions were as
described for the insert, but with six units of enzyme per
µg of vector DNA. The digested vector was purified in the
same way as the insert, but using a 1% agarose gel.
Ligations were incubated overnight at 16°C using 100 ng
cut vector, 40 ng insert, 1 µl 10x ligation buffer (Roche),
0.5 U T4 DNA ligase and water to a final volume of 10.5
µl. The ligated product was first purified using a QIAquick
PCR purification kit followed by a diffusion desalting step
[46].
The desalted DNA was electroporated into Epicurian Coli
Electroporation-Competent TG1 cells (Stratagene, USA)
using a Biorad Gene Pulser II electroporator set on 1700
V, 200 Ω and 25 µF with 0.1 cm electroporation cuvettes.
After electroporation the bacterial cells were immediately
transferred to 1 ml SOC medium. After 1 hour (h) at 37°C
in a shaking incubator they were plated onto 243 × 243
mm TYE agar plates (15 g agar, 8 g NaCl, 1 g tryptone, 5 g
yeast in 1 l double distilled deionised water) supple-
mented with 100 µg/ml ampicillin and 2% glucose. Addi-BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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tional serial dilutions were plated to determine the library
size. After an overnight incubation at 30°C the bacteria
were scraped off the plates in 2x TY (16 g tryptone, 10 g
yeast extract, 5 g NaCl dissolved in 1 l double distilled
deionised water) supplemented with 100 µg/ml ampicil-
lin and 2% glucose (2x TY A/G). The bacterial suspensions
were stored as 15% glycerol stocks at -70°C. Ligations and
electroporations were repeated until the required number
of primary clones was obtained.
For the sublibrary containing synthetically randomised
VH CDR3 areas, the VH gene, the linker sequence and the
VL genes were amplified separately prior to joining all
three components by overlap extension [32]. The VH gene
was prepared as described for the naïve library. Nine dif-
ferent subrepertoires were constructed, each with a differ-
ent synthetically randomised VH CDR3 region ranging in
size from six to 14 amino acid residues. The primer on the
5' end of VH gene (Sfi1L) was the same for all nine sub-
repertoires, whereas nine different primers were used on
the 3' end (Rand6VH, Rand7VH etc.; see Table 1). Ampli-
fication of the joined genes after SOE [31] was performed
by using primer set Sfi1L/LCNOT1. The linker fragment
was amplified with primer set GSfor/GSrev2 using a DNA
template obtained from a sequenced clone in the naïve
library. All the methods and conditions as used for the
naïve sublibrary were implemented except for the SOE
reactions where 40 ng VL DNA, 40 ng VH DNA and 54 ng
of linker per reaction were joined.
Phages were rescued from a pool of TG1 bacteria harbour-
ing representative amounts of all the sublibraries by the
addition of helper phage M13KO7. The phages were
recovered from the supernatant by precipitation with a 1/
5 volume 20% PEG in 2.5 M NaCl. The precipitated
phages displaying antibodies were resuspended in PBS
and stored at -70°C in 15% glycerol.
Antibody selection by panning
Immunotubes (Nunc Maxisorp) were coated overnight at
4°C with 100 µg/ml of the relevant protein or conjugated
hapten dissolved in PBS. For selections on virus particles,
Nunc Polysorp tubes were coated with 20 µg/ml of puri-
fied virus. All subsequent panning steps were performed
at room temperature. The tubes were blocked for 1 h with
2% fat free milk powder (MP). After washing twice with
PBS, approximately 5 × 1012 library phage particles that
had been preincubated for 30 min in 2% MP and 0.1%
Tween-20 were added to each immunotube. Tubes were
first rotated for 30 min before a stationary incubation of
90 min and then washed 20 × with PBS containing 0.1%
Tween 20 (PBS/T) followed by a further 20 washes with
PBS. Phage displayed antibodies were released by incubat-
ing for 10 min with 1.0 ml 100 mM triethylamine (pH
12). The eluate was neutralised by the addition of 0.5 ml
1 M TRIS-HCl (pH 7.4). The neutralised eluate was used
to reinfect exponentially growing TG1 cells prior to
plating on TYE plates containing 2% glucose and 100 µg/
ml ampicillin. After an overnight incubation at 30°C the
bacteria were collected and the phagemids rescued by the
addition of M13KO7 helper phage (helper phage:bacteria
= 20:1). Four such rounds of selection were usually per-
formed. To screen monoclonal phage antibodies, individ-
ual clones were rescued by transferring inocula from
bacterial colonies to the wells of sterile 96 well tissue cul-
ture plates containing 100 µl/well 2x TY A/G. Bacteria
were grown overnight at 30°C with shaking at 250 RPM.
The next day, a 96 well inoculation device (Sigma: Cat. No
R-2508) was used to transfer cells from the master plate to
a fresh plate that contained 150 µl 2x TY A/G per well.
After a 2.5 h incubation at 250 RPM and 37°C, a 50 µl vol-
ume of 2x TY A/G that contained 2 × 109 pfu M13KO7 was
added to each well. The plate was incubated at 37°C for
30 min without shaking. After centrifugation for 10 min
at 600 × g the supernatant fluids were removed and
replaced with 150 µl of 2 X TY that contained 100 µg/ml
ampicillin and 25 µg/ml kanamycin. The plate was then
incubated overnight at 30°C and 250 RPM. After centrif-
ugation for 10 min at 600 × g, the supernatant fluids
containing phage displayed antibodies were collected for
testing in ELISA. To screen for monoclonal soluble scFvs,
colonies were grown overnight in microtitre plates as
above. Cells were then inoculated into wells containing
100  µl of 2x TY A/G, with the glucose concentration
decreased to 0.1%. The cells were incubated at 37°C, with
shaking, for 3 h after which 50 µl of 2x TY that contained
100 µg/ml ampicillin and 3 mM isopropyl-β-D-thioga-
lactopyranoside was added to each well. After incubating
for a further 16 h at 30°C and 250 RPM the plates were
centrifuged as above and the supernatant fluids were
tested in ELISA.
Polyclonal phage ELISA
Immunoplates (Nunc Polysorp or Maxisorp) were coated
overnight at 4°C with 50 µl/well of the relevant antigens
suspended in PBS. Subsequent steps were performed at
room temperature. Blocking was for 1 h with 300 µl/well
of 2% MP in PBS. Phage displayed antibodies were con-
centrated 25 × by PEG precipitation and then diluted 1/
100 prior to mixing with an equal volume of PBS contain-
ing 4% MP and 0.2% Tween 20. After three washes with
PBS/T, the wells were incubated for 2 h with 50 µl/well of
the phage displayed antibodies. The plate was washed
three times and incubated for 1 h with 50 µl/well of an
HRP/anti-M13 mAb conjugate (Amersham) diluted 1/
5000 in PBS/T containing 2% MP. After a final wash, 50
µl/well of chromogen consisting of 1 mg/ml o-phenylene
diamine and 0.5 µl/ml of a 30% (v/v) hydrogen peroxide
in 0.1 M citrate buffer (pH 4.5) was added. Absorbance
was monitored at 450 nm with the final reading beingBMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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taken at 492 nm after stopping the reaction with an equal
volume of 2 N H2SO4.
Monoclonal fusion phage and scFv ELISAs
The protocol described above was used to show binding
of individual scFvs fused to phage particle clones, except
that the supernatant fluids from centifuged microtitre
plates were diluted 1:1 with PBS containing 0.2% Tween
20 and 4% MP. For selecting individual soluble scFvs, the
detergent was omitted from the diluent for this and all
subsequent steps. Bound phage displayed scFvs were
detected by incubating for 1 h with 50 µl/well of 100 ng/
ml mAb B62-FE2 in PBS/T that contained 2% MP fol-
lowed by incubation for 1 h with 50 µl/well of HRP anti-
mouse conjugate diluted 1/1000 in the same buffer. The
mAb 9E10 which recognises the c-myc epitope tag was
used when detecting soluble scFvs.
DNA sequencing
Phagemid DNA was isolated by means of a QIAprep Spin
Miniprep Kit (QIAGEN) from 5 ml overnight cultures of
single clones grown at 30°C and 250 rpm in 2x TY A/G.
Primers OP52 and M13 rev were used (Table  1). Auto-
mated sequencing was done by the Molecular Biology
Division, Onderstepoort Veterinary Institute. Sequences
were analysed using Staden [47] and Wisconsin GCG [48]
software packages.
Inhibition ELISA
A Polysorp (Nunc) microtitre plate was coated overnight
at 4°C with 50 µl/well of 10 µg/ml BTV-10 in PBS and
blocked as above. Blocking and washing steps were as
before except that all incubations were at 37°C. After
blocking, the plate was incubated for 1 h with 50 µl/well
of the different sera diluted 1/9 in PBS containing 2% MP
followed by an incubation of 1 h with 50 µl/well of phage
antibody H2. PEG precipitated phages were first diluted in
PBS to the pre-precipitation volume and then mixed 1:1
with PBS containing 4% MP and 0.2% Tween 20. Phage
antibodies were detected using the pVIII-specific mAb
B62-FE2 as described above.
Sandwich ELISA
A Polysorp microtitre plate was coated for 1 h at 37°C
with 50 µl/well of 10 µg/ml purified rabbit-IgG in PBS
against either BTV-10 or AHSV-3. Blocking and washing
steps were as described for the inhibition ELISA. The plate
was incubated for 1 h at 37°C with 50 µl/well of the vari-
ous dilutions of virus in PBS containing 2% MP. All sub-
sequent steps from the addition of antibody B62-FE2
onwards were done as described for the inhibition ELISA,
but the incubation times were shortened to 45 minutes.
Expression and purification of soluble scFvs
Individual bacterial clones were grown overnight in 2x TY
A/G at 37°C. A dilution of 1/100 was made in the same
medium and the bacteria were allowed to grow until the
OD600 reached a value of 0.9. The cells were collected by
centrifugation and resuspended in a one-fifth volume of
2x TY containing 100 µg/ml ampicillin and 1 mM IPTG.
After overnight incubation at 30°C, followed by
centrifugation, scFvs were affinity-purified from the super-
natant fluid using an anti c-myc tag mAb. Six milligrams of
mAb 9E10 IgG was immobilised on AminoLink Plus gel
(Pierce) according to the manufacturer's instructions.
Medium containing the scFvs was passed over the column
at least three times. After washing with 14 ml PBS, the
bound scFvs were eluted with 5 ml 100 mM triethylamine
and neutralised with 2.5 ml 1 M Tris pH 7.4. The eluted
scFvs were concentrated by centrifugation in an Ultrafree
Biomax unit (10K NMWL, Millipore) to approximately
300 µl. The concentration was determined spectrophoto-
metrically with an A280 of 1.0 corresponding to 0.7 mg/ml
scFv and 1 mg/ml = 40 nM scFv.
Surface plasmon resonance
Kinetic binding constants were determined by surface
plasmon resonance using a BIACORE X instrument
(BIACORE, Uppsala, Sweden). Experiments were
performed at 25°C using HBS-EP running buffer (10 mM
HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% sur-
factant P20) throughout. Bound scFvs were removed with
10 µl of 0.1 M glycine pH 2.5. Fluorescein-biotin (Sigma)
was diluted in PBS to 10 pg/ml and allowed to bind to the
surface of a streptavidin coated chip (Biacore). A blank
flow cell was used as a reference surface. The immobilised
hapten produced a signal of 12 RU. Anti-fluorescein scFvs
ranging from 0.2 to 3.3 nM diluted in HBS-EP were
injected over the chip at a flow rate of 30 µl/min for 70
seconds and allowed to dissociate for the same time.
Horse heart cytochrome C (Sigma) was covalently bound
to the dextran surface of a CM5 chip via its primary amine
groups (BIAapplications handbook, BIACORE). A volume
of 35 µl of cytochrome C (10 µg/ml diluted in 10 mM ace-
tate buffer, pH 5.5) was injected and unreacted ester
groups were blocked with 1 M ethanolamine-HCl, pH 8.5.
These conditions resulted in 3,200 RU being immobi-
lised. In the control flow cell 2,000 RU of chicken egg lys-
ozyme was immobilised under the same conditions. Two
different batches of anti-cytochrome C scFvs were injected
at concentrations ranging from 2.9 nM to 17 pM. KLH was
similarly immobilised using 35 µl of the protein at a con-
centration of 15 µg/ml in 10 mM acetate buffer, pH 4.5.
After blocking unreacted groups, 10 µl of 25 mM NaOH
was injected to remove unbound KLH. This resulted in
10,523 RU being bound. The second flow cell was left
empty. Again two different batches of anti-KLH scFvs were
injected, at concentrations ranging from 0.5 nM to 10 nM.BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/6
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All kinetic analyses were done with BIAevaluation soft-
ware according to the 1:1 Langmuir model using values
obtained after subtracting the reference signal.
Abbreviations
AHSV African horsesickness virus
BSA bovine serum albumin
BTV bluetongue virus
CDR complementarity determining region
CMV cucumber mosaic virus
CYT cytochrome C
D diversity (region of immunoglobulin gene)
EDC N-ethyl-N'-(dimethylaminopropyl) carbodiimide
F-BSA fluorescein conjugated to bovine serum albumin
H heavy (chain)
h hour
HRP horseradish peroxidase
J joining (region of immunoglobulin gene)
KLH Keyhole limpet haemocyanin
L light (chain)
mAb monoclonal antibody
min minute
MP fat free milk powder
NHS N-hydroxysuccinimide
N-BSA 4-hydroxy-3-iodo-5-nitrophenylacetic acid conju-
gated to bovine serum albumin
PBS/T PBS containing 0.1% Tween 20
pfu plaque-forming units
RPM revolutions per minute
RU resonance units (in BIACORE analysis)
scFv single chain variable fragment
TEL turkey egg lysozyme
U unit (of enzyme)
V variable (region of immunoglobulin gene)
2x TY A/G 2x TY supplemented with 100 µg/ml ampicillin
and 2% glucose
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